| Dr Howard M Rosen, MD | |
|
2790 Clay Edwards Dr, Suite 1250, North Kansas City, MO 64116-3260 | |
| (816) 421-3700 | |
| (816) 421-1654 |
| Full Name | Dr Howard M Rosen |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2790 Clay Edwards Dr, North Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922042696 | NPI | - | NPPES |
| 203143409 | Medicaid | MO | |
| 110056196 | Other | RAILROAD MEDICARE | |
| 16692018 | Other | MO | BCBS OF KANSAS CITY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | R7J21 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Howard M Rosen, MD 2790 Clay Edwards Dr, Suite 1250, North Kansas City, MO 64116-3260 Ph: (816) 421-3700 | Dr Howard M Rosen, MD 2790 Clay Edwards Dr, Suite 1250, North Kansas City, MO 64116-3260 Ph: (816) 421-3700 |
News Archive
The National Institutes of Health (NIH) has awarded $10 million to the Georgia Institute of Technology, Emory University and PATH, a Seattle-based nonprofit organization, to advance a technology for the painless, self-administration of flu vaccine using patches containing tiny microneedles that dissolve into the skin.
The increased mortality risk observed among patients with severe psychiatric illness, including schizophrenia, does not seem to be attributable to use of psychopharmacologic therapy, study findings indicate.
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray, the therapeutic equivalent to the reference listed drug Imitrex Nasal Spray, of GlaxoSmithKline.
Bristol-Myers Squibb Company and Ambrx, Inc. today announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein, for potential use in treating type 2 diabetes, and the Relaxin hormone, for potential use in treating heart failure.
The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.
› Verified 3 days ago
Dr. Iris Acosta Comes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr, Suite 240, North Kansas City, MO 64116 Phone: 816-455-0681 Fax: 816-455-5294 | |
Dr. Nicholas Andrew Szilagye, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2700 Clay Edwards Dr, Suite 400, North Kansas City, MO 64116 Phone: 816-421-4240 Fax: 816-421-5015 | |
Dr. Rajya L Malay, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 520, North Kansas City, MO 64116 Phone: 816-221-6750 Fax: 816-221-7280 | |
Dr. Varaporn Treemaneekarn, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr, Suite 400, North Kansas City, MO 64116 Phone: 816-421-4240 Fax: 816-421-5015 | |
Stephenson Coe Hudson, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116 Phone: 816-455-0681 Fax: 816-455-5294 | |
Dr. Lancer Gentry Gates, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr Ste 200a, North Kansas City, MO 64116 Phone: 816-968-9320 | |
Dr. Mark Ernest Gordon, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2700 Clay Edwards Dr, Suite 400, North Kansas City, MO 64116 Phone: 816-421-4240 Fax: 816-421-5015 |